Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Results Survey of Safety and Efficacy of Long-term (104 Weeks) Use of Duodopa Enteral Solution in Patients With Parkinson's Disease in Actual Usage Condition

NCT02906488 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02906488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02906488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Results Survey of Safety and Efficacy of Long-term (104 Weeks) Use of Duodopa Enteral Solution in Patients With Parkinson's Disease in Actual Usage Condition
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
September 12, 2016
Completion date
July 24, 2025
Enrollment
839 (actual)
Sites
127

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease